β2-Adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: Importance of the duration of β2-adrenoceptor stimulation

British Journal of Pharmacology

Volumn 121, Issue 3, 1997, Pages 361-368

  Stewart, Alastair G ^a   Tomlinson, Paul R ^a   Wilson, John W ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

2 adrenoceptors; Airway smooth muscle; Asthma; Cell growth; Cell proliferation; Fenoterol; Salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; EPIDERMAL GROWTH FACTOR; FENOTEROL; MITOGENIC AGENT; SALBUTAMOL; THROMBIN;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUSCLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HYPERTROPHY; LONG TERM EXPOSURE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TIME;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; BRONCHI; CELL DIVISION; CELLS, CULTURED; DNA; HUMANS; LEUCINE; MUSCLE, SMOOTH; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA-2; THYMIDINE; TIME FACTORS;

EID: 0030976323     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701128     Document Type: Article

References (37)

1. ANDERSON, H.R. (1989). Increase in hospital admissions for childhood asthma: trends in referral, severity, and readmissions from 1970 to 1985 in a health region of the United Kingdom. Thorax, 44, 614-619.
2. BARNES, P.J. (1995). Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med., 152, 838-860.
3. 2-adrenoceptor agonists in asthma. Trends Pharmacol. Sci., 13, 20-23.
4. BARNES, P.J., HOLGATE, S.T., LAITINEN, L.A. & PAUWELS, R. (1995). Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin. Exp. Allergy, 25, 771-787.
5. BARRET, T.E. & STROM, B.L. (1995). Inhaled beta-adrenoceptor agonists: more harm than good? Am. J. Resp. Crit. Care Med., 151, 574-577.
6. CHAPMAN, K.R., KESTEN, S. & SZALAI, J.P. (1994). Regular vs asneeded inhaled salbutamol in asthma control. Lancet, 343, 1379-1382.
7. 2-agonists in the treatment of asthma and chronic obstructive pulmonary disease? Chest, 107, 1116-1124.
8. DJUKANOVIC, R., ROCHE, W.R. WILSON, J.W., BEASLEY, C.R., TWENTYMAN, O. & HOLGATE, S.T. (1990). The role of mucosal inflammation in asthma. State of the art review. Am. Rev. Respir. Dis., 142, 434-457.
9. DUNNILL, M.S., MASSARELLA, G.R. & ANDERSON, J.A. (1969). A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax, 24, 176-179.
10. EBINA, M., TAKAHASHI, T., CHIBA, T. & MOTOMIYA, M. (1993). Cellular hypertrophy and hyperplasia of airway smooth muscle underlying bronchial asthma. A 3-D morphometric study. Am. Rev. Resp. Dis., 148, 720-726.
11. EBINA, M., YAEGASHI, H., CHIBA, R., TAKAHASHI, T., MOTOMIYA, M. & TANEMURA, M. (1990). Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. Am. Rev. Resp. Dis., 141, 1327-1332.
12. ERNST, P., HABBICK, B., SUISSA, S., HEMMELGARN, B., COCKROFT, D., BUIST, A.S., HORWITZ, R.I., MCNUTT, M. & SPITZER, W.O. (1993). Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am. Rev. Respir. Dis., 148, 75-79.
13. 2-agonist, terbutaline, with inhaled corticosteroid, budesonide, in newly detected asthma. N. Engl. J. Med., 325, 388-392.
14. 2-adrenoceptor desensitization in cultured human airway smooth muscle. Clin. Sci., 84, 151-157.
15. HALL, I.P., WIDDOP, S., TOWNSEND, P. & DAYKIN, K. (1992). Control of cyclic AMP levels in primary cultures of tracheal smooth muscle cells. Br. J. Pharmacol., 107, 422-428.
16. HIRST, S.J. & TWORT, C.H. (1992). The proliferative response of airway smooth muscle. Clin. Exp. Allergy, 22, 907-915.
17. HOSSAIN, S. (1973). Quantitative measurement of bronchial muscle in men with asthma. Am. Rev. Respir. Dis., 107, 99-109.
18. JAMES, A.L., PARE, P.D. & HOGG, J.C. (1989). The mechanisms of airway narrowing in asthma. Am. Rev. Respir. Dis., 139, 242-246.
19. JEFFERY, P.K., WARDLAW, A.L., NELSON, F.C., COLLINS, J.V. & KAY, A.B. (1989). Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am. Rev. Respir. Dis., 140, 1745-1753.
20. KUWANO, K., BOSKEN, C.H., PARE, P.D., BAI, T.R., WIGGS, B.R. & HOGG, J.C. (1993). Small airways dimensions in asthma and chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 148, 1220-1225.
21. MOHAMMAD, M.A. & SPARROW, M.P. (1989). The distribution of heavy chain isoforms of myosin in airways smooth muscle from adult and neonatal humans. Biochem. J., 260, 421-426.
22. MORLEY, J. (1993). Immunopharmacology of asthma. Trends Pharmacol. Sci., 14, 208-213.
23. NIALS, A.T., COLEMAN, R.A., JOHNSON, M., MAGNUSSEN, H., RABE, K.F. & VARDEY, C.J. (1993). Effects of β-adrenoceptor agonists in human bronchial smooth muscle. Br. J. Pharmacol., 110, 1112-1116.
24. 2-agonists. Lancet, 337, 717-720.
25. SEARS, M.R., TAYLOR, D.R., PRINT, C.G., LAKE, D.C., LI, Q., FLANNERY, E.M., YATES, D.M., LUCAS, M.K. & HERBISON, G.P. (1990). Regular inhaled beta-agonist treatment in bronchial asthma. Lancet, 336, 1391-1396.
26. SKALLI, O., ROPRAZ, P., TRZECIAK, A., BENZONANA, G., GILLESSEN, G. & GABBIANI, G. (1986). A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol., 103, 2787-2796.
27. 2-agonists and the risk of death and near death from asthma. N. Engl. J. Med., 326, 501-506.
28. STEWART, A.G., FERNANDES, D. & TOMLINSON, P.R. (1995a). The effect of glucocorticoids on proliferation of human cultured airway smooth muscle. Br. J. Pharmacol., 116, 3219-3226.
29. STEWART, A.G., TOMLINSON, P.R. & J. WILSON. (1993). Airway wall remodelling in asthma: a novel target for the development of anti-asthma drugs. Trends Pharmacol. Sci., 14, 275-279.
30. STEWART, A.G., TOMLINSON, P.R. & J. WILSON. (1995b). Regulation of airway wall remodelling: prospects for the development of novel anti-asthma drugs. Adv. Pharmacol., 33, 209-253.
31. TOMLINSON, P.R., WILSON, J.W. & STEWART, A.G. (1994). Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br J. Pharmacol., 111, 641-647.
32. TOMLINSON, P.R., WILSON, J.W. & STEWART, A.G. (1995). Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. Biochem. Pharmacol., 49, 1809-1819.
33. 2-adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax, 43, 674-678.
34. VAN ESSEN-ZANDVLIET, E.E., HUGHES, M.D., WAALKENS, H.J., DUIVERMAN, E.J., POCOCK, S.J., KERREBIJN, K.F. AND THE DUTCH CHRONIC NON-SPECIFIC LUNG DISEASE STUDY GROUP. (1992). Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am. Rev. Respir. Dis., 146, 547-554.
35. VAN SHAYCK, C.P., GRAAFSMA, S.J., VISCH, M.B., DOMPELING, E., VAN WEEL, C. & VAN HERWAARDEN, C.L.A. (1990). Increase bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitisation to salbutamol. J. Allergy Clin. Immunol., 86, 792-800.
36. WALLENSTEIN, S., ZUCKER, C.L. & FLEISS, J.L. (1980). Some statistical methods useful in circulation research. Circ. Res., 47, 1-9.
37. WIGGS, B.R., BOSKEN, C., PARE, P.D. & HOGG, J.C. (1992). A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 145, 1251-1258.